24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Medical Disorders
Resources
Basic InformationLookupsLatest News
Hot Water Soak May Help Ease Poor Leg CirculationHealth Tip: Understanding RosaceaHealth Tip: Causes of Swollen Lymph NodesAHA News: Study Provides Rare Look at Stroke Risk, Survival Among American IndiansCDC Opens Emergency Operations Center for Congo Ebola OutbreakScared Safe: Pics of Sun's Damage to Face Boost Sunscreen UseNo Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in BloodBats Are Biggest Rabies Danger, CDC SaysEmgality Receives First FDA Approval for Treating Cluster HeadacheZerbaxa Approved for Hospital-Acquired Bacterial PneumoniaBlood From Previously Pregnant Women Is Safe for Donation: StudyStudy Refutes Notion That People on Warfarin Shouldn't Eat Leafy GreensCancer Survivors Predicted to Top 22 Million by 2030Your Guide to a Healthier Home for Better Asthma ControlHigh Blood Pressure at Doctor's Office May Be More Dangerous Than SuspectedAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideHealth Tip: Dealing With Motion SicknessHealth Tip: Symptoms of MeningitisRace Affects Life Expectancy in Major U.S. CitiesVitamin D Supplements Don't Prevent Type 2 Diabetes: StudyChickenpox Vaccine Shields Kids From Shingles, TooWhooping Cough Vaccine Effectiveness Fades With Time: StudyOpioids Put Alzheimer's Patients at Risk of Pneumonia: StudyHealth Tip: Early Signs of Lyme DiseaseHealth Tip: Hiccup Home RemediesSheep Study Shows a Stuffy Side Effect of VapingShould Air Quality Checks Be Part of Your Travel Planning?Health Tip: Preventing Swimmer's EarHeartburn Drugs Again Tied to Fatal RisksHealth Tip: Nasal Spray SafetyFDA Approves First Drug to Help Tame Cluster HeadachesMany Dietary Supplements Dangerous for TeensAverage American Ingests 70,000 Bits of Microplastic Each YearFalls Are Increasingly Lethal for Older AmericansChicken No Better Than Beef for Your Cholesterol?Another Use for Beta Blockers? Curbing A-fibCaffeine, Nicotine Withdrawal Can Cause Problems in the ICU: StudyYounger Gout Patients Have Higher Odds for Blood ClotsFDA Approves First Test for Zika in Human BloodCDC Warns Again of Salmonella From Pet HedgehogsWhy Some Kids With Eczema Are at Higher Allergy RiskMany Heart Failure Patients Might Safely Reduce Use of DiureticsU.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1992: CDCForget Fasting Before That Cholesterol TestU.S. Cancer Cases, Deaths Continue to Fall'Controlled Burns' Better for Kids' Health Than Wildfires: StudyHighly Processed Diets Tied to Heart Disease, Earlier DeathHealth Tip: Signs of Irritable Bowel SyndromeA Less Invasive Fix Works Well for Abdominal AneurysmFace Transplants Improve Lives Years Later
Questions and AnswersLinks
Related Topics

Diabetes

Eczema Can Drive People to Thoughts of Suicide: Study

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Dec 12th 2018

new article illustration

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- Nearly 28 million Americans are affected by the skin condition eczema, and for some it may become so chronic and severe they consider suicide, new research shows.

A new review of data from 15 studies, involving over 300,000 people, found that those with eczema had a 44 percent higher risk of suicidal thoughts compared with people without the immunological disease.

People with eczema also had a 36 percent higher rate of suicide attempts, the study found.

Eczema, clinically known as atopic dermatitis, often brings a "profound psychosocial burden" to patients, concluded a team led by Dr. April Armstrong, of the University of South California (USC) Keck School of Medicine, Los Angeles.

Eczema is an inflammatory skin condition that often involves painful itch, blisters and sores. People can also have trouble sleeping due to itchiness and other symptoms.

The disease can vary in severity and can be socially debilitating, prior research has shown. One such study involved 600 eczema patients interviewed by researchers at Northwestern University in Chicago.

That study found that even for people with mild eczema, nearly 18 percent said they avoided socializing because of their appearance, while 23 percent said they limited their daily activities. Those figures rose to 40 percent and 43 percent, respectively, when moderate and severe patients were included.

The findings were published in July in the Annals of Allergy, Asthma and Immunology.

In the new study, the USC team found similar issues plaguing eczema patients.

"Because of the visibility of the disease, patients may experience shame, embarrassment and stigmatization," Armstrong's team said. This can affect a child's performance at school or an adult's ability to thrive in the workforce, they explained.

To learn more, the investigators analyzed data from 15 studies on eczema's emotional toll on patients.

The findings showed that "patients with atopic dermatitis are at significantly greater risk of suicidal ideation and suicide attempts," and the level of distress rose along with the severity of the skin disease, according to the report.

For example, while less than one percent of people with mild eczema said they had suicidal thoughts, that number rose to nearly 20 percent for those with severe disease, the researchers found.

Two skin specialists weren't surprised by the findings.

Eczema "can be mentally stressful for patients who suffer from it," said Dr. Michele Green, a dermatologist at Lenox Hill Hospital in New York City. She believes the study reinforces the need for treatments that minimize the illness, to help patients mentally cope.

Dr. Raman Madan practices dermatology at Northwell Health's Huntington Hospital in Huntington, N.Y. He said that people with eczema often have to deal with concurrent health issues -- conditions such as asthma, allergic rhinitis (hay fever), metabolic syndrome and sleep disturbances.

Now, the new study "casts light that dermatologists should screen for mental health in [these] patients," as well, Madan said.

For their part, Armstrong's team stressed that treatments that ease eczema severity are available.

Immune-targeted treatments, "such as interleukin 4 and interleukin 13, have been shown to decrease symptoms of depression and anxiety in patients," the study authors wrote. And as physical symptoms subside, and the social stigma around the illness eases, "we can work toward reducing suicidality in patients with [eczema]," the team noted.

The new findings were published online Dec. 12 in JAMA Dermatology.

More information

For more on eczema, visit the U.S. National Institute of Allergy and Infectious Diseases.